Inherited Retinal Diseases Often Involve Complex “Diagnostic Odyssey”
Patients with rare inherited retinal diseases often must undertake a diagnostic odyssey before receiving a correct diagnosis.
Read MoreDec 18, 2023
Patients with rare inherited retinal diseases often must undertake a diagnostic odyssey before receiving a correct diagnosis.
Read MoreDec 14, 2023
Do you remember the MS research presented at AAN? Test your knowledge now and see how you rank!
Read MoreDec 14, 2023
Do you remember the psoriasis research presented at Fall Clinical Dermatology Conference 2023? Test your knowledge now!
Read MoreDec 11, 2023
In age-related macular degeneration, depression can directly impact patient care through loss to follow-up, cancellations, and lack of treatment adherence.
Read MoreDec 9, 2023
At 2023 NACLC, Heather Law, MA, presented a recap of “Associations of HRQOL with daily functioning/communication with care teams in patients with ALK+ NSCLC.”
Read MoreDec 6, 2023
Decision support tools help patients with MS more effectively engage with their providers and adhere to their treatment.
Read MoreDec 6, 2023
Do you remember the eNSCLC research presented at ESMO? Test your knowledge now!
Read MoreDec 5, 2023
The following is a summary of “Benefit of Allogeneic Transplant in 1st Complete Remission in...
Read MoreDec 5, 2023
The following is a summary of “Autologous Transplant (auto-HCT) Is Associated with Improved...
Read MoreDec 5, 2023
The following is a summary of “Addition of Acalabrutinib to Lenalidomide and Rituximab...
Read MoreDec 4, 2023
April Armstrong, MD, MPH, spoke with Physician’s Weekly about the role of interleukin inhibitors, IL-17 and IL-23, in treating psoriasis.
Read MoreDec 4, 2023
With over 275 exhibitors, the 65th ASH Annual Meeting exhibit hall is not to be missed!
Read MoreDec 4, 2023
Sign up today for the virtual 2023 ASH Foundation Run/Walk!
Read MoreDec 4, 2023
Make the most of your attendance at the 65th ASH annual meeting by utilizing these helpful resources to plan your schedule and stay informed!
Read MoreDec 4, 2023
The following is a summary of “Real-World Effectiveness and Safety Outcomes of Acalabrutinib...
Read MoreDec 3, 2023
At 2023 NACLC, Xiaohan Hu presented “Real-World Patients Characteristics, Biomarker Testing & Adjuvant Therapy for Resected NSCLC at US Oncology Clinics, 2019-2023”
Read MoreDec 3, 2023
At the 2023 NACLC, Benjamin Lok, MD, FRCPC, presented a radiation “mini-debate” focused on the “Goldie Locks Effect.”
Read MoreDec 3, 2023
At the 2023 NACLC, Florian Fintelman, MD, presented a recap of data on the use of artificial intelligence for lung cancer risk prediction on chest CT.
Read MoreDec 1, 2023
Forget the O’Hare food kiosks and grab lunch at one of these locations instead, all within easy walking distance from the Chicago Marriott Downtown Magnificent Mile
Read MoreDec 1, 2023
Don’t miss the 2023 NACLC closing keynote—Perioperative Therapy—to be given by Jonathan Spicer, MD, PhD, 11:15 a.m.-12:15 p.m., Sunday, December 3, 2023.
Read More